洞察RAS驱动的黑色素瘤及其治疗影响
Eftychia Chatziioannou1, Konstantinos Lallas2, Tobias Sinnberg3
1Department of Dermatology, University Hospital Tübingen, Liebermeisterstr. 25, 72076 Tübingen, Germany.
Cancer treatment reviews
|January 23, 2026
概括
拉斯突变驱动黑色素瘤,目前的治疗方法,如抗PD-1疗法,对晚期病例的疗效有限. 新兴疗法,包括向RAS抑制剂和突变特异性免疫疗法,为个性化黑色素瘤治疗提供了新的希望.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 免疫学 免疫学 免疫学
背景情况:
- NRAS突变发生在15-25%的皮肤黑色素瘤中,主要发生在61.
- 皮肤黑色素瘤中KRAS变化较少,但在大脑转移和粘膜/膜亚型中更为频繁.
研究的目的:
- 审查RAS突变黑色素瘤的当前和新兴治疗策略.
- 突出个性化,基于生物标志物的治疗方法的潜力.
主要方法:
- 对RAS突变黑色素瘤的当前全身疗法和研究方法的文献综述.
- 分析新兴的向疗法,包括MEK抑制剂,RAF抑制剂和新型RAS特异性抑制剂.
- 探索免疫疗法策略,包括基于新位基的疫苗.
主要成果:
- 目前的全身疗法依赖于抗PD-1免疫检查点抑制,而MEK抑制剂由于耐药性而显示出适度的益处.
- 组合策略 (例如,MEK与RAF抑制剂) 和试验药物 (例如,G12C抑制剂,泛RAS抑制剂,mRNA疫苗) 正在开发中.
- 来自NRAS Q61K的新表位体显示出免疫性,支持突变特异性免疫疗法.
结论:
- 新兴疗法准备彻底改变RAS驱动的黑色素瘤管理.
- 个性化,基于生物标志物的策略对于优化RAS突变黑色素瘤患者的治疗结果至关重要.
相关概念视频
The Ras Gene
7.1K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.1K
Small GTPases - Ras and Rho
5.2K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
5.2K
Therapeutic Index
6.7K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.7K
ATP Driven Pumps I: An Overview
9.8K
ATP-driven pumps, also known as transport ATPases, are integral membrane proteins. They have binding sites for ATP located on the membrane's cytosolic side and the ion-conducting domain in the transmembrane region. These pumps use the free energy released from ATP hydrolysis to move the solutes across cell membranes against an electrochemical gradient.
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
9.8K
Therapeutic Communication
7.7K
Communication is a lifelong learning process. Through therapeutic communication, nurses can collect relevant assessment data, provide education and counseling, and interact during nursing interventions. Sending and receiving messages occur through verbal and nonverbal communication techniques and can happen separately or simultaneously.
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
7.7K
Microorganisms in Medicine and Therapeutics
1.0K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.0K


